Mechanism of Action of Cholestyramine for Bile Acid Diarrhea
Cholestyramine is a positively charged, non-digestible anion exchange resin that binds bile acids in the intestinal lumen, forming an insoluble complex that is excreted in feces, thereby preventing bile acid absorption in the terminal ileum and reducing the colonic bile acid load that triggers secretory diarrhea. 1, 2
Molecular Mechanism
Cholestyramine adsorbs and combines with bile acids in the intestine through ionic binding to form an insoluble complex that cannot be absorbed. 2 This binding action:
- Removes bile acids from the enterohepatic circulation by preventing their reabsorption in the terminal ileum 2, 3
- Increases fecal excretion of bile acids, leading to partial depletion of the bile acid pool 2
- Forces hepatic oxidation of cholesterol to synthesize replacement bile acids 2
Pathophysiology in Bile Acid Diarrhea
In patients with ileal resection, cholecystectomy, or Crohn's disease affecting the terminal ileum, excessive bile acids reach the colon where they induce increased secretion of salt and water, causing secretory diarrhea. 4, 5
By sequestering bile acids in the gut lumen before they reach the colon, cholestyramine reduces the colonic bile acid load and thereby minimizes bile acid-induced fluid secretion. 1, 4
Clinical Context for Specific Conditions
Post-Cholecystectomy Diarrhea
After gallbladder removal, continuous bile flow into the intestine (rather than regulated postprandial release) leads to elevated fecal bile acid excretion and diarrhea in susceptible patients. 6, 7 Cholestyramine binds these excess bile acids, with dramatic clinical response in patients with documented bile acid malabsorption showing fecal bile acids 3-10 times normal levels. 7
Ileal Resection
Resection of 40-150 cm of ileum causes malabsorption of bile acids, increasing the colonic bile acid load. 4 Cholestyramine reduces diarrhea by binding bile acids in the colon without interfering with jejunal fat absorption when using enteric-coated formulations. 4
Crohn's Disease with Terminal Ileal Involvement
Terminal ileal inflammation or resection impairs bile acid reabsorption, leading to bile acid malabsorption in approximately 28% of patients with chronic diarrhea. 5 The mechanism of cholestyramine action is identical: binding excess bile acids to prevent colonic secretion. 8, 5
Important Mechanistic Considerations
Cholestyramine does not reduce total fecal bile acid output or correct bile acid malabsorption—it simply prevents absorbed bile acids from reaching the colon where they cause secretory diarrhea. 4 This explains why:
- Response rates correlate with severity of bile acid malabsorption: 96% response with <5% SeHCAT retention, 80% with <10% retention, and 70% with <15% retention 9
- Lack of response to cholestyramine does not exclude bile acid diarrhea, as 44% of patients with documented bile acid malabsorption fail cholestyramine alone 9
Critical Pitfall
In patients with extensive ileal resection (>100 cm), cholestyramine can paradoxically worsen steatorrhea by binding bile acids needed for fat digestion in the small intestine, increasing caloric loss. 10, 11 In these patients, avoid bile acid sequestrants entirely. 10, 11